2. Gene
  3. Fes - FES proto-oncogene, tyrosine kinase Gene

Fes - FES proto-oncogene, tyrosine kinase Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Rattus norvegicus

Also known as RGD1564385

Gene ID: 361597 | Gene type: protein coding

About Fes

Summary

Predicted to enable several functions, including immunoglobulin receptor binding activity; microtubule binding activity; and non-membrane spanning protein tyrosine kinase activity. Predicted to be involved in several processes, including positive regulation of cellular component organization; positive regulation of monocyte differentiation; and protein phosphorylation. Predicted to act upstream of or within centrosome cycle and microtubule bundle formation. Predicted to be located in cytoplasm; focal adhesion; and microtubule Cytoskeleton. Predicted to be extrinsic component of cytoplasmic side of plasma membrane. Predicted to colocalize with cytoplasmic vesicle. Orthologous to human FES (FES proto-oncogene, tyrosine kinase). [provided by Alliance of Genome Resources, Apr 2022]

Fes Products(1)

mRNA Protein Name
NM_001108488.1 NP_001101958.1 tyrosine-protein kinase Fes/Fps
Gene Ontology
  • Biological Process
Biological Process GO Annotation Evidence Reference Source
involved in cardiac muscle cell proliferation IEP
IEP: Inferred from expression pattern
2447874 RGD
involved in myoblast proliferation IEP
IEP: Inferred from expression pattern
2425941 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

tyrosine-protein kinase Fes/Fps

feline sarcoma oncogene

Related Agents

Approval
Bioactive Molecules (10)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0988 Deferoxamine mesylate 99.94% Unkown
HY-B1625 Deferoxamine 99.76% Yes
HY-16168A Degarelix 99.94% Unkown
HY-107928 Iron dextran / Unkown
HY-17609 Difelikefalin Agonist 99.98% Unkown
HY-B1306 4-Aminohippuric acid 99.84% Unkown
HY-16564 Deferasirox (Fe3+ chelate) Inhibitor ≥98.0% Unkown
HY-108017 Ferric maltol 99.93% Yes
HY-16168B Degarelix acetate hydrate / Unkown
HY-16168 Degarelix acetate Antagonist / Unkown
Clinical Phase
Bioactive Molecules (7)
Cat. No. Product Name Effect
Purity Phase
HY-12040 Elesclomol 99.80% Phase 3
HY-P1714 Apraglutide 99.33% Phase 3
HY-105239A Selepressin acetate Agonist 98.77% Phase 3
HY-P1714A Apraglutide TFA 98.69% Phase 3
HY-105239 Selepressin Agonist 99.34% Phase 3
HY-122844 Ifebemtinib Inhibitor 99.86% Phase 2
HY-P3516 Barusiban Antagonist / Phase 2
Pre-clinical Phase
Bioactive Molecules (69)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-D1533 RhoNox-1 98.54% Unkown
HY-W004544 o-Phenanthroline Inhibitor 99.96% Unkown
HY-137805 Ferrozine 99.96% Unkown
HY-D1913 FerroOrange 98.2% Unkown
HY-N0928 Mimosine Inducer 99.92% Unkown
HY-126823 Phen Green SK diacetate (5/6-mixture) 95.33% Unkown
HY-W075707 FeTCPP chloride ≥95.0% Unkown
HY-N10473 Pulcherriminic acid Inhibitor ≥98.0% Unkown
HY-128525 Enterobactin Inhibitor 99.64% Unkown
HY-D0945 Xylene Cyanol FF 97.46% Unkown
HY-145157 Ferric nitrilotriacetate ≥98.0% Unkown
HY-Y1841 o-Phenanthroline monohydrate Inhibitor 99.95% Unkown
HY-P3267A Apo-Bovine Transferrin Activator ≥95.0% Unkown
HY-D0221 2,4,6-Tri-2-pyridinyl-1,3,5-triazine 99.87% Unkown
HY-163897 PROTAC NCOA4 degrader-1 Inhibitor 99.42% Unkown
HY-158739 Rhodamine dithenoyl hydrazide 98.00% Unkown
HY-156776 HAPSBC ≥95.0% Unkown
HY-107928B Iron–Dextran(Fe 35-40% w/w) / Unkown
HY-136300 PHD-1-IN-1 Inhibitor 99.21% Unkown
HY-145286 IMPDH2-IN-2 99.73% Unkown
HY-B1250 Acedoben 99.42% Unkown
HY-N0046 Notoginsenoside Fe 99.94% Unkown
HY-155539 Cisd2 agonist 2 Agonist 99.17% Unkown
HY-158779 Sulfane sulfur probe 4 97.3% Unkown
HY-W015600 2-Acetamidophenol 99.61% Unkown
HY-D2339 H-FluNox 99.53% Unkown
HY-B1250A Acedoben sodium 99.99% Unkown
HY-B1159S Nitroxoline-d4 / Unkown
HY-160414 TRX-COBI Inhibitor / Unkown
HY-B1306S 4-Aminohippuric acid-d4 ≥98.0% Unkown
HY-W112021 2,5-DMBQ 99.99% Unkown
HY-W112939 Fe(III)(TDCPP) chloride 95.00% Unkown
HY-N13871 Anguibactin Inhibitor / Unkown
HY-100332 CP 375 / Unkown
HY-115832 Ap44mSe / Unkown
HY-12040S Elesclomol-d2 / Unkown
HY-138185 Collismycin A Inhibitor / Unkown
HY-143249 MtMetAP1-IN-1 Inhibitor / Unkown
HY-149418 BChE/HDAC6-IN-2 Inhibitor / Unkown
HY-155158 Anticancer agent 147 Inducer / Unkown
HY-157917 Nitro-PAPS disodium dihydrate / Unkown
HY-157926 Nitroso-PSAP / Unkown
HY-159943 ROS151 Inhibitor / Unkown
HY-16168AS Degarelix-d7 Antagonist / Unkown
HY-162812 H3R antagonist 4 Inhibitor / Unkown
HY-162933 AChE-IN-77 Inhibitor / Unkown
HY-170433 DefNEtTrp Inducer / Unkown
HY-172092 BG11 Inducer / Unkown
HY-174867 AY-4 Agonist / Unkown
HY-176212 Ferroptosis-IN-20 Inhibitor / Unkown
HY-D2204 SHP1-IN-1 Inhibitor / Unkown
HY-D2730 N14G-Fe Inhibitor / Unkown
HY-E70311 TLL-10X / Unkown
HY-RS04867 FES Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W004544S o-Phenanthroline-d8 Inhibitor / Unkown
HY-W011816 1,2-Hexadecanediol 99.73% Unkown
HY-W686216 VK-28 97.17% Unkown
HY-148340 24RBPyBC / Unkown
HY-17609C Difelikefalin acetate Agonist / Unkown
HY-17609S Difelikefalin-d5 Agonist / Unkown
HY-N14059 Halymecin B / Unkown
HY-N14060 Halymecin C / Unkown
HY-N15282 Broussoflavonol G / Unkown
HY-N15398 Chaetoglobosin E Inducer / Unkown
HY-RS18447 Fes Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24929 Fes Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W009022 Diantipyrylmethane 98.98% Unkown
HY-W130303 Diacetamide / Unkown
HY-W151629A Ferrozine sodium hydrate / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Fes NCBI NCBI:2242